Viewing Study NCT04882735


Ignite Creation Date: 2025-12-24 @ 10:34 PM
Ignite Modification Date: 2025-12-29 @ 10:26 PM
Study NCT ID: NCT04882735
Status: WITHDRAWN
Last Update Posted: 2024-09-19
First Post: 2021-04-29
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Efficacy and Safety of Acoramidis (AG10) in Subjects with Transthyretin Amyloid Polyneurophathy (ATTRibute-PN)
Sponsor: Eidos Therapeutics, a BridgeBio company
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module